Hematopoietic Cell Transplantation for Myelofibrosis: DIPSS Plus Risk Predicts Post-transplant Outcomes

Hematopoietic cell transplantation (HCT) provides potentially curative treatment for patients with myelofibrosis (MF). HCT outcomes are associated with the Dynamic International Prognostic Scoring System (DIPSS) risk scores. In the present study, we analyzed results in 233 patients to determine if t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Samuelson Bannow, Bethany T., Salit, Rachel B., Storer, Barry E., Stevens, Emily A., Wu, David, Yeung, Cecilia, Fang, Min, Petersdorf, Effie W., Linenberger, Michael L., Woo, Janghee, Sorror, Mohamed L., Doney, Kris, Sandmaier, Brenda M., Deeg, H. Joachim, Scott, Bart L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6481667/
https://ncbi.nlm.nih.gov/pubmed/28970176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.09.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados